
Wockhardt Investor Relations Material
Latest events

Q1 25/26
8 Aug, 2025

Q4 24/25
29 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wockhardt Limited
Access all reports
Wockhardt Limited is a pharmaceutical and biotechnology company engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company operates across therapeutic areas including anti-infectives, cardiology, neurology, and diabetes care. It has manufacturing and research facilities that comply with international regulatory standards and serves both domestic and global markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
WOCKPHARMA
Country
🇮🇳 India